These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 20484178)

  • 1. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
    ; Zisman DA; Schwarz M; Anstrom KJ; Collard HR; Flaherty KR; Hunninghake GW
    N Engl J Med; 2010 Aug; 363(7):620-8. PubMed ID: 20484178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis.
    Jackson RM; Glassberg MK; Ramos CF; Bejarano PA; Butrous G; Gómez-Marín O
    Lung; 2010 Apr; 188(2):115-23. PubMed ID: 20012639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction.
    Han MK; Bach DS; Hagan PG; Yow E; Flaherty KR; Toews GB; Anstrom KJ; Martinez FJ;
    Chest; 2013 Jun; 143(6):1699-1708. PubMed ID: 23732584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
    Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
    Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil for chronic obstructive pulmonary disease: a randomized crossover trial.
    Lederer DJ; Bartels MN; Schluger NW; Brogan F; Jellen P; Thomashow BM; Kawut SM
    COPD; 2012 Jun; 9(3):268-75. PubMed ID: 22360383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil in idiopathic pulmonary fibrosis.
    Mubarak K
    N Engl J Med; 2010 Nov; 363(22):2170; author reply 2170-1. PubMed ID: 21105802
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
    Redfield MM; Chen HH; Borlaug BA; Semigran MJ; Lee KL; Lewis G; LeWinter MM; Rouleau JL; Bull DA; Mann DL; Deswal A; Stevenson LW; Givertz MM; Ofili EO; O'Connor CM; Felker GM; Goldsmith SR; Bart BA; McNulty SE; Ibarra JC; Lin G; Oh JK; Patel MR; Kim RJ; Tracy RP; Velazquez EJ; Anstrom KJ; Hernandez AF; Mascette AM; Braunwald E;
    JAMA; 2013 Mar; 309(12):1268-77. PubMed ID: 23478662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis.
    Kolb M; Raghu G; Wells AU; Behr J; Richeldi L; Schinzel B; Quaresma M; Stowasser S; Martinez FJ;
    N Engl J Med; 2018 Nov; 379(18):1722-1731. PubMed ID: 30220235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design.
    Behr J; Nathan SD; Harari S; Wuyts W; Kirchgaessler KU; Bengus M; Gilberg F; Wells AU
    Respir Med; 2018 May; 138():13-20. PubMed ID: 29724385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.
    Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ;
    Chest; 2011 Nov; 140(5):1274-1283. PubMed ID: 21546436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease.
    Zeng WJ; Lu XL; Xiong CM; Shan GL; Liu ZH; Ni XH; Gu Q; Zhao ZH; Li JJ; He JG;
    Clin Cardiol; 2011 Aug; 34(8):513-8. PubMed ID: 21678455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of high dose generic sildenafil in Thai patients with pulmonary arterial hypertension.
    Durongpisitkul K; Pornrattanarungsi S; Panjasamanvong P; Chungsomprasong P
    J Med Assoc Thai; 2011 Apr; 94(4):421-6. PubMed ID: 21591526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis.
    Swigris JJ; Streiner DL; Brown KK; Belkin A; Green KE; Wamboldt FS;
    Respir Med; 2014 Jan; 108(1):181-8. PubMed ID: 24388667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.
    Wirostko BM; Tressler C; Hwang LJ; Burgess G; Laties AM
    BMJ; 2012 Feb; 344():e554. PubMed ID: 22354598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension.
    Jones LA; Klimberg IW; McMurray JG; Padula R; Tseng LJ; Stecher VJ
    J Sex Med; 2008 Aug; 5(8):1955-64. PubMed ID: 18564150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial.
    Behr J; Nathan SD; Wuyts WA; Mogulkoc Bishop N; Bouros DE; Antoniou K; Guiot J; Kramer MR; Kirchgaessler KU; Bengus M; Gilberg F; Perjesi A; Harari S; Wells AU
    Lancet Respir Med; 2021 Jan; 9(1):85-95. PubMed ID: 32822614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil in idiopathic pulmonary fibrosis.
    Maher TM
    N Engl J Med; 2010 Nov; 363(22):2169; author reply 2170-1. PubMed ID: 21105804
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase III, multicenter, collaborative, open-label clinical trial of sildenafil in Japanese patients with pulmonary arterial hypertension.
    Satoh T; Saji T; Watanabe H; Ogawa S; Takehara K; Tanabe N; Yamada N; Yao A; Miyaji K; Nakanishi N; Suzuki Y; Fujiwara T; Kuriyama T
    Circ J; 2011; 75(3):677-82. PubMed ID: 21304214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil: a review of its use in pulmonary arterial hypertension.
    Croom KF; Curran MP
    Drugs; 2008; 68(3):383-97. PubMed ID: 18257613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.